George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Bought in today after over reacted drop by the mm's. Asset's if needed to be sold outweighs the current M/C.
This is certainly value for money and would expect sp not to last at this level for too long.
Recent Director's buys at 21p should give a clear indication the companies was good value a week or two ago.
I be surprised not to see the sp back to 15-18p until further news.
The drop in Diamonds are always for a reason, Shut down/Slow down production = Short stock = Prices increase.
Nevertheless drilling has started and Majors will be in negotiations as TOM proves its method. Only a few weeks before confirmation so not much time left to conclude a contract and value for Tom's patent method
Quote
Further to the Company's announcement of 4 July, the Company is pleased to announce that the Field Test is running to schedule, with drilling works having already commenced and the Field Test team is due to arrive on site next week ahead of commencing the live testing phase of TurboShale Inc.'s RF technology in early August.
Andrew Jones, Chairman, commented: "I'm sure shareholders will agree, this is a very exciting time for the Company. I would like to thank John and the team for all their hard work and we look forward to providing further updates over the coming weeks as the Field Test progresses."
Agree, Majors are watching this very carefully. I would expect a few have already been in negotiations and probably have agreed terms to its patent. £25-£50M is chicken feeder this type of production.
It will be just a formality for these majors to actually witness the evidence of proof.
No doubt we will wake up to re-rate of the SP followed by RNS stating buy out or rights to this Patent without reservations, leaving anyone sitting on the side lines never a chance to buy any shares with so few available
Orders being filled and these buys are not being shown. I know as I have seen buys being filled.
MM's are dropping to fill there sold orders in advance of the results. Typical weak sellers don't understand the true value of TOM's method of production. All proven and once the final test shows the evidence of oil this will be 15p plus.
Liquidity is so low here, seen how quickly this will jump once the final batch of buys are filled. Meanwhile weak sellers are taking bait.
This Director was only interested in the mining aspects of the company. Now OVB has concentrated on LIBICORE which has now been successful he has no part to play in medical play of this product. Rns is a simple way of asking him to leave.
A plus for the company so all their focus is on full production for Russia.
Quote RNS
Ovoca Bio plc (LSE: OVB; ISE: OVXA) announces that Yuri Radchenko, a Non-Executive Director of the Company, has notified the board of his intention to step down with immediate effect due to personal circumstances.
Should land any time now. Once this been granted the production lines can start rolling out the product ready for the huge market that awaits.
Millions of people will get prescribed immediately and see short term supply outstrip production levels.
I would image when the US & Rest of Europe get the go ahead too this will have huge impact on the current M/C.
I am expecting min £25-50M M/C re-rate on the first production alone
John Potter, TomCo's Chief Executive Officer, said:
"The main objective of the Field Test is to recover oil using TurboShale's RF technology by heating kerogen in-situ. With the extensive survey work undertaken in the period and the expansion of the project team our confidence in meeting our objective is very high."
The positive side here thou is funding required after final testing. With the confidence of the CEO stating a successful test results, I would expect if no JV then funding will be above 15p plus. Thats still only a M/C of £18M.
The patent alone will be worth so much more so can easily see M/C @ at this level during final testing phase results
Milton
Nice holding won't be long before we reach placing price 5.2p plus now.
I suspect they have kept the sp down to fill their ever increasing order. MM's will now let this go.Lets hope back to 6-8p short term
fjones40
I suggest you read this in details then confirm what your understanding is because to me nothings changed and funds required.We only have funds to the tests. What happens in Oct 2019 ?
RNS 26th June 2019 reads
As at 27 June 2019, TomCo had approximately GBP626,000 of cash available to it. The Group has sufficient funds to complete the Field Test and through to the beginning of October 2019, when it will need to raise further funding in order to meet its liabilities and commitments as they fall due as well as to provide additional working capital for the Group
I think peeps are being caution here as the last Rns did state funding will be required. I hope they wait when the sp is higher but stated possibly during final testing period hence why we need to break the 7p barrier
Silence Therapeutics plc (SLN) Ordinary 5p (View Factsheet)
Sell: 160.00p | Buy: 153.00p | up16.66p (11.99%)
Sell 160
Buy 153 ! but can't buy any !!!
Now 158 to buy 156 to sell !
Crazy HL giving 157 to sell 156 to buy! got to be £2 by close
Latino
These series of sells are just shorts/ stop limits etc being triggered off by computers. We need these sells for liquidity otherwise there is no market for the mm's to play with.
Lets say you buy at 138p, and to protect your investment place a limit to drop 135p. The markets will just take this out if there are no shares available. Hence why the erratic up/down we have been seeing.
Either way this company will be over £2 very soon.
US market opens shortly see this rise close to £2
I do think a buy out of the Patent is diffidently going to happen here. So much progress has been achieved to get to this stage.
The question is how much is this worth ? We know R & D cost many £10's M's and years of companies time and effort.
£25-£50M ? would still be very cheap considering the scale and sole patent of this product.
Some info for the markets to wake up too.
Once the filed licence gets the approval, production will commence. This product is massive, can't see M/C at this level for much longer. Only 81.56M shares in issue. Even at 30p that's only a M/C of @ £24M. Plenty cash in the bank too.
Letter from the CEO:
With the successful conclusion of last year's acquisition of IVIX LLC ("IVIX") and the re-admission of the enlarged group on Euronext Dublin and the London Stock Exchange, the foundation was put in place for establishing Ovoca as a recognized developer of novel therapeutics for women's health, especially in the area of sexual dysfunction. Our colleagues at IVIX continue to build out our successful BP101 program, which you will have seen in March 2019 comfortably exceeded the efficacy and safety hurdles in its Phase 3 trial in Russia. As a result, we are now preparing to file for the drug's marketing approval in its first country, the Russian Federation, and actively pursuing discussions with potential licensing partners to commercialize there.
Boris Reznik, chairman of Biorasi added: "We are very excited to begin this project with Ovoca/IVIX. Their BP-101 drug candidate has shown promising performance in clinical trials so far, and we believe there is high potential in bringing it over to the EU and US markets."